- $6.77bn
- $7.00bn
- $1.11bn
- 83
- 73
- 96
- 98
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 868 | 955 | 1,029 | 1,001 | 1,110 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 198 | 456 | 198 | -2.97 | 257 |
Operating Profit | 669 | 499 | 831 | 1,004 | 853 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 659 | 490 | 822 | 988 | 823 |
Provision for Income Taxes | |||||
Net Income After Taxes | 556 | 413 | 682 | 831 | 696 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 556 | 413 | 682 | 831 | 696 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 556 | 413 | 682 | 831 | 696 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.66 | 3.88 | 6.11 | 7.72 | 6.54 |
Dividends per Share |